The Foundation for Peripheral Neuropathy (FPN) is delighted to announce that Sandra Rieger, PhD, has joined the Foundation’s Scientific Advisory Board (SAB). The SAB advises both the Board of Directors and staff of the Foundation in areas of science and technology relevant to peripheral neuropathy and its research. Dr. Sandra Rieger earned a Ph.D. in Developmental […]
Thank you for your continued support and interest in our programs! The Foundation for Peripheral Neuropathy provides education and support today as we walk toward a cure for tomorrow. Support us in advancing a cure! FPN is a non-profit organization that is solely funded by our readers. Donate Now! […]
NIH Award Will Support Research by Sandra Rieger, Ph.D., on Nerve Damage Induced by Cancer Chemotherapy BAR HARBOR, MAINE — The MDI Biological Laboratory has announced that Sandra Rieger, Ph.D., has been awarded a highly competitive grant from the National Cancer Institute, an institute of the National Institutes of Health (NIH), to study the molecular […]
Read More… from MDI Biological Laboratory Scientist Receives Grant to Study Peripheral Neuropathy
by Dr. Thomas Smith and Dr. Charles Loprinzi What is neuropathic pain, from the non-expert oncologist’s point of view? The way we think of it, pain is about the most protective instinct and impulse known to humans! If you touch a hot plate, you retract your hand even before you actually feel the pain. Then, the […]
Read More… from Scrambler Therapy for Treating Neuropathic Pain
Genetic Bio Marker may Predict Chemo-Induced Peripheral Neuropathy Side Effects Associated with Prostate Cancer Treatment New study finds genetic alterations in the VAC14 gene are associated with an increased risk of chemo-induced peripheral neuropathy in prostate cancer patients. Taxanes are a group of drugs commonly used to treat cancers of the breast, lung, ovary, or prostate, […]
Read More… from Chemo-Induced Peripheral Neuropathy may be Predicted by Genetic Bio Marker
A team of researchers at The University of Texas MD Anderson Cancer Center (TX, USA) have discovered a link between the use of neurofeedback and a decrease in personal experience of chronic pain in patients with chronic chemotherapy-induced peripheral neuropathy (CIPN). The results help to expand knowledge of neuropathic pain and a chemotherapy side effect that […]